Allied Minds and Bristol-Myers Squibb Form Enterprise to Advance Biopharmaceutical Discoveries

AM_blackAllied Minds (LSE: ALM), a U.S. science and technology development and commercialization company, and Bristol-Myers Squibb Company (NYSE: BMY) formed a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S.

Allied-Bristol Life Sciences LLC will focus on converting discoveries from university research institutions into therapeutic candidates for clinical development, and approved therapies that address serious diseases.
It will form and fund new companies to conduct feasibility and full-phase discovery programs. Once a program succeeds in identifying a pre-clinical candidate, Bristol-Myers Squibb will have the option to acquire the company from Allied-Bristol Life Sciences LLC under pre-agreed terms.



Join the discussion